Medsafe Logo


REGULATORY INFORMATION

Home  |  Consumers  |  Health Professionals  |  Regulatory  |  Other  |  Hot Topics  |  Search

Medicines Assessment Advisory Committee

Revised:  April 2013

Terms of reference
The Medicines Assessment Advisory Committee (MAAC) is a technical advisory committee established under section 8 of the Medicines Act 1981 to advise the Minister of Health on the risk-benefit profile of new medicines.

The Terms of Reference of the MAAC are as follows:

Meetings
The MAAC is scheduled to meet three times a year (usually in March, June and September). Secretarial support is provided by Medsafe.

The 97th meeting of the MAAC is scheduled to take place on Wednesday 24 July 2013.

Membership
The MAAC comprises up to 12 members, with:

Members are appointed for a three year term, which may only be renewed once.

Medsafe is always willing to hear from suitably experienced candidates who are willing to be considered for appointment by the Minister of Health, even during a period when specific appointments are not being sought:

Nominations sought for the MAAC